MAC
64
2
SJM
48
2
AES
58
3
QCOM
57
-2
EIX
74
2
STI
31
-2
SRCL
44
-11
APA
30
6
NRG
72
-2
PPL
67
3
FE
56
4
MUR
48
4
DE
56
3
ES
56
8
LMT
62
3
TJX
51
-3
APH
55
-4
LRCX
53
-3
PCG
83
3
NWS
47
2
MAC
64
2
SJM
48
2
AES
58
3
QCOM
57
-2
EIX
74
2
STI
31
-2
SRCL
44
-11
APA
30
6
NRG
72
-2
PPL
67
3
FE
56
4
MUR
48
4
DE
56
3
ES
56
8
LMT
62
3
TJX
51
-3
APH
55
-4
LRCX
53
-3
PCG
83
3
NWS
47
2
Financhill
Back

Western Alliance Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
69

WAL
Western Alliance Bancorp

Last Price:
85.59
Seasonality Move:
4.61%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
69
Western Alliance Bancorp (WAL) is a Buy

Is Western Alliance Bancorp a Buy, Sell or Hold?

  • The current Western Alliance Bancorp [WAL] share price is $85.58. The Score for WAL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • WAL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WAL Stock Price Chart

What is Western Alliance Bancorp's stock price today?

  • The Western Alliance Bancorp share price today is $85.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WAL is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

WAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.17 Buy
Relative Strength Index (14 RSI): 61.05 Buy
Chaikin Money Flow: -229044 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.55 - 85.13) Buy
Bollinger Bands (100): (62.06 - 80.3) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

WAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.91 Sell
20-day SMA: 82.71 Buy
50-day SMA: 79.51 Buy
200-day SMA: 66.14 Buy
8-day EMA: 84.99 Buy
20-day EMA: 83.12 Buy
50-day EMA: 78.78 Buy
200-day EMA: 67.2 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Western Alliance Bancorp Earnings Growth & WAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.49 per share, a decrease this year of $0.46 per share, and an increase next year of $1.80 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Western Alliance Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):